LSD1 inhibition could attenuate inflammation in the renal cortex of HBV-Tg mice (Fig. 8) Therefore, LSD1 might be a potential target in the intervention of HBV-GN progression. This evidence concerns the gene KDM1A and ganglioneuroma.